A Diverse Team of

Powerful Leaders

OUR TEAM OF EXPERTS

Founded in 2011 by Dr. Marcus Martin (CEO) and Dr. Eddilisa Martin (President), 2M Clinical is led by a diverse team of experts with extensive hands-on experience in every aspect of clinical trials and research. Our collective knowledge of the pharmaceutical and healthcare sectors and substantial work with regulatory bodies makes us a powerful ally and smart strategic partner.

Eddilisa Martin

  • BS
  • PharmD
  • 25+

Owner & CEO

Dr. Eddilisa Martin has over 25 years of clinical and health outcomes research and executive leadership experience. Her research expertise is in clinical research, pharmacoeconomics, and comparative effectiveness research. She has served as a therapeutic expert across several areas, including cardiovascular disease, diabetes, oncology, immunology, and anti-infective pharmacology.

Dr. Martin also has extensive experience interfacing with providers (hospitals, physicians, ancillary providers) to improve healthcare outcomes, healthcare service utilization, and costs. Prior to her leadership role with 2M, Dr. Martin served as a national medical liaison with Abbott Labs for 19 years. She received her Doctor of Pharmacy Degree from the University of Oklahoma Health Science Center and her Bachelor of Pharmacy Degree from the University of Arkansas Medical Sciences Center. She is licensed to practice pharmacy in the states of Texas and Arkansas.

Contact: eddilisa.martin@2mclinical.com



We want all patients to be able to make healthcare decisions based on clinical research data that reflects them.

- EM -

Marcus Martin

  • PhD
  • MPH
  • 25+

Co-Founder

Dr. Marcus Martin has more than 25 years of experience and training in epidemiology and outcomes research. He is responsible for 2M’s corporate vision, strategic growth, and talent acquisitions. Dr. Martin is a first-generation college graduate who attended college on a football scholarship at the University of Louisiana at Monroe.

Dr. Martin received his PhD from Howard University with concentrations in Sociology and Applied Statistics and his MPH from the University of North Texas Health Science Center School of Public Health with concentrations in Population Health and Epidemiology. Dr. Martin also received a Master of Arts and his undergraduate Degree from the University of Louisiana. He is a former faculty member at the University of Oklahoma and has a current adjunct faculty appointment in the School of Public Health at the University of North Texas Health Science Center. Dr. Martin’s vision for 2M Clinical developed after the unexpected death of his 22-year-old brother in 1997 and his success in helping a close family member enroll in a clinical trial that saved her life in 1997. Twenty-five years later, that family member is one of the longest living patients ever enrolled in this still ongoing clinical trial.

Dr. Martin is the author of an upcoming memoir that is scheduled to be released on October 2, 2021: The Biggest Dreams in the Neighborhood. The book focuses on life lessons Dr. Martin learned as a poor black kid growing up in a small, shotgun-style house in Southern Louisiana.  Despite his family’s meager resources while he was growing up and his early academic struggles, Dr. Martin believes he had a perfect childhood even while living in imperfect conditions—because he always managed to have the biggest dreams in the neighborhood.

His success as an athlete, academic, and entrepreneur has been developed and defined more often by failures than success.  However, Dr. Martin believes failure is success—especially for a young person starting off at the bottom with absolutely nothing to lose.

At the age of 52, Dr. Martin’s remaining life’s goal is to help support efforts that will create equitable and healthy communities in America and increase the pipeline of minority entrepreneurs in America.

Contact: marcus.martin@2mclinical.com



Everyone deserves an opportunity to enroll in a clinical trial regardless of race, gender, age, geography, or socioeconomic status.

- MM -

Scott Schliebner

  • MPH
  • 25+

Executive Vice President & Chief Strategy Officer

Scott Schliebner is a clinical strategist with a 25-year background in drug development focused on rare diseases, orphan drugs, and patient-focused approaches. He develops innovative solutions to help overcome the operational, logistical, and ethical challenges inherent to conducting research with rare disease patients.

Mr. Schliebner’s efforts are focused on patient-centered approaches to drug development, reducing the burden of clinical trial participation, and leveraging novel and disruptive technologies to bring new therapies to patients faster. Mr. Schliebner also serves on the Board of Directors and on the Scientific Advisory Board for Uplifting Athletes and has developed active partnerships with other patient-focused organizations, patient advocacy groups, drug development institutes, and academic research centers. Scott received a master’s degree in Public Health focused on cancer epidemiology from the University of Utah School of Medicine and completed a Graduate Research Fellowship at The National Institutes of Health. Prior to joining 2M Clinical, Scott served as Senior Vice President at PRA Health Sciences. While at PRA Health Sciences, Scott served as the executive leader for PRA teams comprised of the Center for Vaccine Research, Center for Ophthalmology Research, Center for Advanced Therapeutics, and Digital Therapeutics. As an industry leader and innovator, Scott launched the CRO industry’s first Patient Advisory Committee to ensure patient-focused practices are being emphasized and to ensure the patient voice is incorporated into clinical development. Scott created and developed the PRA Center for Rare Diseases, a multidisciplinary business unit which was responsible for developing innovative solutions to overcome the challenges of research in rare disease populations. Under Scott’s leadership the Center for Rare Diseases conducted more than 350 clinical studies.

Contact: scott.schliebner@2mclinical.com



Dustin Arnold

  • 25+

Chief Technology Officer

Mr. Dustin Arnold is a software architect, developer, and executive with deep technical and business experience in product and platform development. He is a business-minded technologist with a passion for leading 2M’s efforts to use cutting edge tools and technologies to drive our business success.

Early in his career, he was a co-founder of Skywire Software, where he led the delivery of software and technology for nonprofit, insurance, and financial service clients. Since then, he has been responsible for the design and delivery of software for the public and private sector, including systems used by most of the Fortune 500 companies.  Mr. Arnold has significant recent experience in software, data, and cloud technology for the healthcare industry. Utilizing data across provider networks, insurers, and brokers, their systems provided healthcare navigation services to consumers, saving money and improving the quality of healthcare for patients.

Contact: dustin.arnold@2mclinical.com



Practice isn't the thing you do once you're good. It's the thing you do that makes you good.

M. Gladwell